Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Directorate Change

2 Aug 2021 07:00

RNS Number : 1378H
Chesnara PLC
02 August 2021
 

CHESNARA plc

("Chesnara" or "the Company")

 

02 August 2021

 

LEI Number: 213800VFRMBRTSZ3SJ06

 

 

CHESNARA PLC CHANGE OF DIRECTORSHIP

and REMUNERATION ARRANGEMENTS FOR CEO-ELECT

 

On 12 May 2021, Chesnara announced that John Deane intended to retire from the Company and to step down as Group Chief Executive by the end of the year. Chesnara also announced that it had identified Steve Murray as intended successor to the role of Group Chief Executive.

 

Steve Murray has today been appointed an Executive Director of Chesnara and Countrywide Assured plc. Upon securing regulatory approval, he will become Chesnara's Group Chief Executive.

 

Steve held a number of awards under the various incentive plans of his previous employer, The Royal London Mutual Insurance Society, and replacement awards will be granted upon his appointment as Group Chief Executive in line with Chesnara's Remuneration Policy.

- A cash payment will be made to Steve upon appointment to compensate for the value of his 2018 Royal London STIP which was forfeited on cessation.

- He will be granted buy-outs of other Royal London awards using the approved Chesnara Long Term Incentive- and Short Term Incentive- schemes. Steve's 2021 Royal London STIP will be met through the Chesnara Short Term Incentive Scheme, with 65% to be paid in cash to the extent it vests in April 2022 and 35% as share options deferred in line with the scheme. In the case of the Royal London long term incentives, the Chesnara grants will be struck at the closing price on the day that his regulatory approval is received. Should Chesnara be in a Closed Period at that time, these grants will be struck at the closing price of the first day's trading after that Closed Period comes to an end.

 

Full disclosure of these remuneration arrangements will be provided in the Directors' Remuneration Report to be published in 2022.

 

For further information, please contact:

 

 

Roddy Watt

Director, Capital Markets

FWD

Forward thinking communications

 

T - 020 7280 0651

E - roddy.watt@fwdconsulting.co.uk 

 

 

Notes to Editors

Chesnara is a life and pensions company listed on the London Stock Exchange. It administers over one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.

 

Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests. It also adds value by writing profitable new business in Sweden and the Netherlands and by undertaking value-adding acquisitions of either companies or portfolios.

 

Consistent delivery of the Company strategy has enabled Chesnara to increase its dividend for 16 years in succession.

 

Further details are available on the Company's website (www.chesnara.co.uk).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOARMMATMTAJBIB
Date   Source Headline
22nd Oct 20195:11 pmRNSHolding(s) in Company
2nd Oct 20195:11 pmRNSHolding(s) in Company
30th Sep 20195:00 pmRNSTotal Voting Rights
30th Sep 20192:33 pmRNSHolding(s) in Company
20th Sep 20199:00 amRNSHolding(s) in Company
19th Sep 20195:00 pmRNSHolding(s) in Company
12th Sep 20195:24 pmRNSHolding(s) in Company
9th Sep 20192:11 pmRNSDirector/PDMR Shareholding
2nd Sep 20197:00 amRNSDirector/PDMR Shareholding
29th Aug 20197:00 amRNSHalf-year Report
6th Aug 20194:40 pmRNSNotice of Results
31st Jul 20197:00 amRNSTotal Voting Rights
31st May 20197:00 amRNSTotal Voting Rights
29th May 20197:00 amRNSDirector/PDMR Shareholding
14th May 20192:34 pmRNSResult of AGM
7th May 20191:23 pmRNSHolding(s) in Company
30th Apr 20197:00 amRNSDirector/PDMR Shareholding
25th Apr 20197:00 amRNSBlock listing Interim Review
16th Apr 20197:00 amRNSNotice of AGM
12th Apr 201910:17 amRNSHolding(s) in Company
29th Mar 20197:00 amRNSFinal Results
15th Mar 20197:00 amRNSNotice of Results
31st Dec 20187:00 amRNSTotal Voting Rights
17th Dec 20185:36 pmRNSDirectorate Change
13th Dec 20189:30 amRNSDirector/PDMR Shareholding
12th Dec 20187:00 amRNSHolding(s) in Company
30th Nov 20187:00 amRNSTotal Voting Rights
6th Nov 20188:27 amRNSDirector/PDMR Shareholding
25th Oct 20187:00 amRNSBlock listing Interim Review
1st Oct 20187:00 amRNSNew Senior Independent Director
30th Aug 20187:00 amRNSHalf-year Report
6th Aug 20183:37 pmRNSNotice of H1 Results
10th Jul 20187:00 amRNSHolding(s) in Company
6th Jul 20187:00 amRNSHolding(s) in Company
5th Jul 20187:00 amRNSHolding(s) in Company
21st May 20185:16 pmRNSPDMR and Total Voting Rights
16th May 20183:58 pmRNSResults of AGM
1st May 20187:00 amRNSDirector/PDMR Shareholding
24th Apr 20187:00 amRNSChesnara plc - Application for Block Listing
17th Apr 20187:00 amRNSNotice of AGM and Annual Report & Accounts
29th Mar 20187:00 amRNSFinal Results
15th Mar 20187:00 amRNSNotice of Results
14th Mar 201810:47 amRNSHolding(s) in Company
8th Mar 201810:13 amRNSHolding(s) in Company
5th Mar 20182:29 pmRNSExternal Chair appointment for Mike Evans
12th Jan 20183:05 pmRNSHolding(s) in Company
6th Dec 201710:21 amRNSTotal Voting Rights
4th Dec 20172:39 pmRNSHolding(s) in Company
24th Nov 201710:08 amRNSDirector/PDMR Shareholding
24th Nov 20177:00 amRNSCapital Markets Day

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.